Blog
News

Blog

Corporate News

Technical Documentation

Application Articles

Frequently Asked Questions

2023/03/02

The innovative pharmaceutical market continues to expand, with capital increasingly favoring the Hong Kong Stock Connect healthcare sector.

The innovative pharmaceutical market continues to expand, with capital increasingly favoring the Hong Kong Stock Connect healthcare sector.

According to a report by the Foresight Industry Research Institute, China’s innovative pharmaceutical market has experienced rapid growth, driven by favorable policies, dynamic adjustments to the national medical insurance system, and increased R&D investment.

The innovative pharmaceutical market continues to expand, with capital increasingly favoring the Hong Kong Stock Connect healthcare sector.

2023/03/02

Expanded authorization for batch release of biological products accelerates product market launch.

Expanded authorization for batch release of biological products accelerates product market launch.

To enhance the efficiency of batch release for biological products (vaccines), the National Medical Products Administration has decided, on the basis of a thorough risk assessment, to progressively expand the scope of provincial drug regulatory authorities’ testing and inspection institutions authorized to carry out batch release for biological products (vaccines), as well as the range of product types covered.

Expanded authorization for batch release of biological products accelerates product market launch.

2023/03/02

Multiple Pharmaceutical Companies Collaborate to Advance the Development of Cancer Immunotherapy Drugs

Multiple Pharmaceutical Companies Collaborate to Advance the Development of Cancer Immunotherapy Drugs

Several globally leading pharmaceutical companies have announced a collaboration to jointly advance the research and development of cancer immunotherapy drugs.

Multiple Pharmaceutical Companies Collaborate to Advance the Development of Cancer Immunotherapy Drugs

2023/03/02

Gene-Editing Technologies Empower Rare Disease Drug Development

Gene-Editing Technologies Empower Rare Disease Drug Development

As gene-editing technologies continue to mature, their application in the development of therapies for rare diseases is becoming increasingly widespread.

Gene-Editing Technologies Empower Rare Disease Drug Development
< 12 >